Outrun Therapeutics

👥 10 employees💰 Last funded Apr 2021
Biotechnology Research🌐 outruntx.com
Website LinkedIn
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in Outrun Therapeutics?
Outrun Therapeutics has 1 investors on record on gritt.io.
When did Outrun Therapeutics last raise funding?
The most recent investment in Outrun Therapeutics recorded on gritt.io was in April 2021.
What industry is Outrun Therapeutics in?
Outrun Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.